Navigation Links
Baylor University scientist receives major grants for health research on 1991 Gulf War veterans
Date:11/1/2012

WACO, Texas (Nov. 1, 2012) - Baylor University has been awarded two new federal grants for research on Gulf War illness, the complex medical condition that affects veterans of the 1991 war. The grants, from the Office of Congressionally Directed Medical Research Programs of the U.S. Department of Defense, total nearly $1.6 million, and bring current federal funding for Baylor's Gulf War research program to over $2.3 million.

"These grants will support our intensive effort to find answers for the many thousands of veterans still suffering from Gulf War Illness," said Lea Steele, Ph.D., the Baylor University epidemiologist who directs the program. The funding supports projects to address multiple aspects of the problem, including studies on the biological processes causing veterans' symptoms and development of a nationwide network to advance health research, particularly studies leading to effective treatments, for Gulf War illness.

Gulf War illness is the term commonly used for the symptomatic condition that affects military personnel who served in the 1990-1991 Gulf War. Symptoms typically include some combination of chronic headache, widespread pain, memory and concentration difficulties, and digestive and other abnormalities - problems that are not explained by medical or psychiatric diagnoses or by routine laboratory tests.

Studies indicate at least one in four of the 700,000 military personnel who served in the 1990-1991 war are affected, and that few have recovered over time. "Gulf War illness may no longer be as high profile as health issues from more recent wars in Iraq and Afghanistan, but it remains a very serious problem for many thousands of ill veterans," said Steele, who is research professor in the Baylor Institute of Biomedical Studies. "This work is especially important here in Central Texas, which is home to one of the largest concentrations of 1991 Gulf War veterans in the country."

The federal grants awarded to Baylor support three separate projects. For the first study, funded in 2011, Baylor is partnering with Scott & White Healthcare to provide clinical assessments, including an in-depth look at the brain, the immune system, and diverse other measures in Gulf War veterans. "This project should give us a clearer picture of the complex biological processes that drive veterans' symptoms," Steele said. "This is an essential step for improving the care provided for ill veterans."

The second project will focus on developing a blood test to improve the diagnosis of Gulf War illness. According to Steele, "Gulf War illness is currently defined only on the basis of veterans' symptoms. An objective test to assist in diagnosing this condition would be immensely beneficial to veterans and their healthcare providers, and can also provide an important tool to better understand and treat this condition."

The third project includes a national study to determine the current health status of veterans across the U.S. who served in the 1991 Gulf War. It will also establish an information and research network for veterans to receive periodic updates on health issues, and connect veterans with scientists who are conducting health studies of 1991 Gulf War veterans.

Steele has conducted research on the health of Gulf War veterans since 1998. Before joining the Baylor Institute of Biomedical Studies in 2010, she served as scientific director for the federal Research Advisory Committee on Gulf War Veterans' Illnesses.

"After years of false starts," she said, "research has now provided progress in our understanding of Gulf War illness." She emphasized, however, that despite this progress, many veterans remain ill, since doctors still lack effective methods for diagnosing and treating Gulf War illness. She added that "We believe these answers can be found, and are especially pleased to be partnering with Scott & White to address this problem, given its importance for veterans in Central Texas."


'/>"/>

Contact: Frank Raczkiewicz
frank_raczkiewicz@baylor.edu
254-710-1964
Baylor University
Source:Eurekalert

Related biology news :

1. Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
2. University of Toronto study demonstrates impact of adversity on early life development
3. The George Washington University Researcher received $1.7 million to study solar cement
4. The 2013 HFSP Nakasone Award goes to Stephen Quake of Stanford University
5. University of Tennessee, ORNL lead national team to study nuclear fusion reactors
6. Rockefeller Universitys Pearl Meister Greengard Prize to be awarded to RNA researcher Joan Steitz
7. Yale Universitys Joan Steitz awarded 2012 Vanderbilt Prize
8. University of Illinois at Urbana-Champaign awarded 5-year grant from NASA
9. University of Alberta medical scientists first in the world to look at structure of vital molecule
10. University spin-out company shares in £7.9 million marine energy funding boost
11. Rice University researchers optimize photoluminescent probes to study DNA and more
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: